Global Surveillance of Antibiotic Resistance
- 30 January 1992
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (5), 339-340
- https://doi.org/10.1056/nejm199201303260510
Abstract
THE group A β-hemolytic streptococci, of the species Streptococcus pyogenes, can sicken or kill us in many ways. They commonly cause acute pharyngitis. They may initiate rheumatic fever or glomerulonephritis. They also cause scarlet fever, impetigo, erysipelas, pyoderma, puerperal sepsis, wound infection, and a rapidly spreading cellulitis. They can produce a fulminant and fatal septicemia, as was called to public attention recently by the death of Muppets creator Jim Henson. Recent reports, moreover, suggest a resurgence of strains that cause rheumatic fever or fulminant septicemia.1 A cure for group A streptococcal infection was one of the truly extraordinary benefits . . .Keywords
This publication has 9 references indexed in Scilit:
- Resistance to Erythromycin in Group A StreptococciNew England Journal of Medicine, 1992
- More extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1991
- The resurgence of group A streptococcal infections and their sequelaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western AustraliaThe Medical Journal of Australia, 1989
- A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycinEpidemiology and Infection, 1989
- Intercontinental Spread of a New Antibiotic Resistance Gene on an Epidemic PlasmidScience, 1985
- INDUCIBLE ERYTHROMYCIN RESISTANCE IN BACTERIABritish Medical Bulletin, 1984
- Conjugative plasmids in bacteria of the ‘pre-antibiotic’ eraNature, 1983